The Proteasome Inhibitor Bortezomib Prevents Lupus Nephritis in the NZB/W F1 Mouse Model by Preservation of Glomerular and Tubulointerstitial Architecture

TGFβ prevents proteasomal degradation of the cyclin-dependent kinase inhibitor p27kip1 for cell cycle arrest

(2011) Jon Lecanda et al.   CELL CYCLE

Bortezomib: A New Pro-Apoptotic Agent in Cancer Treatment

(2010) A. Russo et al.   CURRENT CANCER DRUG TARGETS

Proteasome inhibitors prevent cisplatin-induced mitochondrial release of apoptosis-inducing factor and markedly ameliorate cisplatin nephrotoxicity

(2009) Ling Liu et al.   BIOCHEMICAL PHARMACOLOGY

Bortezomib suppresses focal adhesion kinase expression via interrupting nuclear factor-kappa B

(2009) Bor-Sheng Ko et al.   LIFE SCIENCES

Bortezomib arrests the proliferation of hepatocellular carcinoma cells HepG2 and JHH6 by differentially affecting E2F1, p21 and p27 levels

(2008) Daniele Baiz et al.   BIOCHIMIE

Proteasome inhibition drastically but reversibly impairs murine lymphocyte development

(2008) D Maseda et al.   CELL DEATH AND DIFFERENTIATION

UCH-L1 expression of podocytes in diseased glomeruli andin vitro

(2008) Yuan Liu et al.   JOURNAL OF PATHOLOGY

Bortezomib-Induced Survival Signals and Genes in Human Proximal Tubular Cells

(2008) R. Sarkozi et al.   JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS

Proteasomal Processing of Albumin by Renal Dendritic Cells Generates Antigenic Peptides

(2008) D. Macconi et al.   JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY

The proteasome inhibitor bortezomib depletes plasma cells and protects mice with lupus-like disease from nephritis

(2008) Kirsten Neubert et al.   NATURE MEDICINE